One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Markenson as of April 28, 2013.
The following firms organize Continuing Medical Education (CME) and promotional programs for which I receive honoraria as a Speaker: Advanced Health Media, Apex Communications, KnowledgePoint 360 Group, Med Ed – Link, Inc., Medical Decisionpoint, LLC, Miller Medical Communications, LLC, PVI Peerview Institute for Medical Education, QED Communications, Inc., Quintiles, Inc., River West Meeting Associates, Inc., The Selva Group, Travel Destination Management Group, Inc., and Y&R, Inc. (DBA Sudler & Hennessey).
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
For more publications, please see the PubMed listing.
Dr. Joseph Markenson is the principal investigator for drug studies involving patients with Rheumatic Diseases (Rheumatoid Arthritis, Osteoarthritis and Lupus). Ongoing recruitment for enrollment in studies currently active. Patients interested in more information or to participate in a Clinical Drug Trial should call his office at 212.606.1261.